Global adoption of single-shot targeted IORT for breast cancer

IORT at the Asian Hospital and Medical Center

The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival

Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast cancer

Choosing Wisely in pathology

Pembrolizumab plus docetaxel used to treat patients with metastatic castration-resistant prostate cancer

SG monotherapy demonstrates a high response rate in PT-ineligible patients with mUC who progressed after CPI therapy

Bladder sparing: Risk-enabled therapy after initiating neoadjuvant chemo allows active surveillance of some MIBC

Genomic profiling of penile squamous cell carcinoma reveals major biomarkers for efficacy of immunotherapy

Pembrolizumab shows notable antitumour activity for patients with high-risk non–muscle-invasive bladder cancer

Plasma miR371 detects MRD and early relapse of germ cell tumours

Cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced RCC